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Abstract
Background: Diagnostic discordance for osteoporosis is the observation that the T-score of an
individual patient varies from one key measurement site to another, falling into two different
diagnostic categories identified by the World Health Organization (WHO) classification system.
This study was conducted to evaluate the presence and risk factors for this phenomenon in a large
sample of Iranian population.
Methods: Demographic data, anthropometric measurements, and risk factors for osteoporosis
were derived from a database on 4229 patients referred to a community-based outpatient
osteoporosis testing center from 2000 to 2003. Dual-energy X-ray absorptiometry (DXA) was
performed on L1–L4 lumbar spine and total hip for all cases. Minor discordance was defined as
present when the difference between two sites was no more than one WHO diagnostic class.
Major discordance was present when one site is osteoporotic and the other is normal. Subjects
with incomplete data were excluded.
Results: In 4188 participants (3848 female, mean age 53.4 ± 11.8 years), major discordance, minor
discordance, and concordance of T-scores were seen in 2.7%, 38.9% and 58.3%, respectively. In
multivariate logistic regression analysis, older age, menopause, obesity, and belated menopause
were recognized as risk factors and hormone replacement therapy as a protective factor against T-
score discordance.
Conclusion: The high prevalence of T-score discordance may lead to problems in interpretation
of the densitometry results for some patients. This phenomenon should be regarded as a real and
prevalent finding and physicians should develop a particular strategy approaching to these patients.
Background
Osteoporosis is defined as a systemic skeletal disease char-
acterized by low bone mass and micro-architectural dete-
rioration of bone tissue, with a consequent increase in
bone fragility and susceptibility to fracture [1,2]. This def-
inition indicates that measurement of bone mineral
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density (BMD) is a central component to diagnosis of the
disease [3].
'T score' is a statistical definition which indicates the dif-
ference between patient's BMD and mean bone density of
normal population in the age of 20 – 30 (reference popu-
lation) [3]. This value shows the difference in terms of
standard deviations. According to the World Health
Organization (WHO) classification system, T scores under
the value of -2.5 are considered as osteoporosis and
between -1 and -2.5 as osteopenia. These figures are usu-
ally calculated separately for two different sites of lumbar
spine and total hip.
Discordance in diagnosis of osteoporosis is defined as
presence of different categories of T scores (osteoporosis,
osteopenia, and normal) in two skeletal sites of an indi-
vidual patient [4]. This phenomenon has been divided
into two groups: major and minor [5]. Minor discordance
happens when the different diagnostic classes are adja-
cent; i.e., patient is diagnosed as osteoporotic in one site
and osteopenic in the other site, or, osteopenic in one site
and normal in the other site. If the diagnosis is osteoporo-
sis in one site and the other site is in the normal range, the
discordance falls into the major class.
Actually, one of the reasons for measuring BMD in several
sites is the presence of discordance, which can affect the
diagnosis and therapeutic plan in an individual person.
Various studies have analyzed the prevalence and impact
of T-score discordance on different aspects of manage-
ment of osteoporosis [5-9]. However, most of these stud-
ies did not evaluate risk factors for this phenomenon.
Given this background and concerning the need for the
estimation of the impact of this phenomenon in our
country, we aimed to evaluate the presence and risk fac-
tors for T-score discordance in a large sample of Iranian
population.
Methods
Participants in this study were 4229 persons who under-
went bone densitometry in outpatient clinic of Endo-
crinology & Metabolism Research Center in Tehran from
2000 to 2003. A considerable proportion of these cases
were healthy post-menopausal women referred by clini-
cians for densitometric evaluations. All study participants
signed the informed consent for any scientific approach to
their medical registered data. Our Institutional Review
Board approved this study.
A standardized questionnaire was filled before densitom-
etry for all participants. Demographic data (including age
and sex) as well as other known or suspicious risk factors
for osteoporosis (including menopause, age at meno-
pause, age at menarche, history of osteoporotic fractures,
drugs, and smoking) were collected. All participants had
their standing height measured using a stadiometer to the
nearest 0.5 cm. Weight was measured on a standard
weighting scale with a precision of 0.5 kg. Body mass
index (BMI) was calculated as weight (kg) divided by
height (m) squared. All the BMD measurements were
done for diagnostic purposes and none of the participants
were on the treatment with bone active agents (hormone
replacement therapy was not considered a bone active
agent).
BMD was measured at the lumbar spine and total hip with
dual X-ray absorptiometry (DXA) using a Lunar DPXMD
densitometer (Lunar 7164, GE, Madison, WI) by a trained
operator according to the manufacturer's instruction. The
instrument was calibrated weekly by using appropriate
phantoms. Precision error for BMD measurements was 1–
1.5% in the lumbar and 2–3% in the femoral regions. The
device normative data of US population for spine BMD
and NHANES III study for femur BMD were used as refer-
ence values.
All the data gained from densitometry and questionnaires
were entered into a comprehensive relational database.
The participants with incomplete data were excluded from
the study. To compare presence of various risk factors in
participants with and without T-score discordance, chi-
square test and independent sample t-test were used
firstly. Potential risk factors were entered to a multivariate
binary logistic regression analysis and the resulted odds
ratios with 95% confidence intervals were reported. P val-
ues less than 0.05 were taken to indicate statistical signif-
icance. Statistical analyses were performed using Stata
Statistical Package, version 8.0 (Stata Corporation, Col-
lege Station, Tx).
Results
In sum, 4188 persons were enrolled in the study. Charac-
teristics of all participants are summarized in Table 1. The
main reasons of referral for BMD measurement were men-
opause in 49%, old age in 16%, glucocorticoid use in 9%,
history of low energy fractures in 1.5%, and other reasons
(such as metabolic disorders, rheumatoid arthritis, posi-
tive family history, leanness, and transplantation) in 4.5%
of participants. In 20% of participants, no major risk fac-
tor was identified as the referral reason.
Totally, 518 participants were diagnosed in osteoporotic
range in hip area and 1036 participants in the lumbar
area. T-score classifications are presented in Table 2. Major
discordance was observed in BMD results of 115 (2.7%)
participants. Minor discordance was observed in 1631
(38.9%) participants and T-score categories of twoBMC Endocrine Disorders 2005, 5:3 http://www.biomedcentral.com/1472-6823/5/3
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Table 1: Characteristics of the study population*
Male participants (n = 340) Female participants (n = 3848)
Age (years) 49.7 (16.3) 53.8 (11.2)
Weight (kilograms) 68.5 (13.1) 67.1 (11.9)
Height (centimeters) 168.5 (7.7) 156.1 (6.1)
Body Mass Index (kg/cm2) 24.1 (4.2) 27.6 (4.7)
History of osteoporotic fracture 8 (2.4) 47(1.2)
Smoking 35 (10.3) 94 (2.4)
Corticosteroid use 89 (26.2) 298 (7.7)
Hormone Replacement Therapy 231 (6.0)
Age at menarche (years) 13.6 (1.5)
Menopause 2137 (55.5)
Age at menopause (years) 47.2 (5.8)
Femoral T score -0.93 (1.24) -1.43 (1.18)
Lumbar T score -1.40 (1.48) -1.45 (1.54)
* Numbers are presented as mean (standard deviation in parenthesis) for numerical variables and frequency (percentage in parenthesis) for categorical 
variables.
Table 2: Classification of T scores according to WHO criteria in different sites*
Lumbar spine Total hip
No. % 95% Confidence 
Intervals
No. % 95% Confidence 
Intervals
Osteoporosis (T = -2.5) 1036 24.7 23.4–26.0 518 12.4 11.4–13.4
Osteopenia (-2.5 < T = -1) 1605 38.3 36.8–39.8 1592 38.0 36.5–39.5
Normal (T > -1) 1547 36.9 35.5–38.4 2078 49.6 48.1–51.1
Table 3: Distribution of diagnostic discordances according to WHO criteria in different genders*
Male participants (n = 340) Female participants (n = 3848) Total (n = 4188)
Major T-score Discordance 7 (2.1) 108 (2.8) 115 (2.7)
Hip Osteoporosis, Normal 
Lumbar
51 6 2 1
Hip Normal, Lumbar 
Osteoporosis
29 2 9 4
Minor T-score Discordance 117 (34.4) 1514 (39.3) 1631 (38.9)
Hip Osteoporosis, Lumbar 
Osteopenia
10 99 109
Hip Osteopenia, Lumbar 
Osteoporosis
39 515 554
Hip Osteopenia, Normal Lumbar 35 220 255
Hip Normal, Lumbar Osteopenia 33 680 713
T-score Concordance 216 (63.5) 2226 (57.8) 2442 (58.3)
Hip and Lumbar Osteoporosis 50 338 388
Hip and Lumbar Osteopenia 93 690 783
Hip and Lumbar Normal 73 1198 1271
* Numbers are presented as frequency (percentage in parenthesis).BMC Endocrine Disorders 2005, 5:3 http://www.biomedcentral.com/1472-6823/5/3
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measurement sites in other 2442 (58.3%) participants
were not different. Distribution and pattern of this varia-
ble in different genders is depicted in Table 3.
T-score discordance was more prevalent in women than
men (42.2% versus 36.5%, P = 0.042). The mean age of
participants with discordance (54.8 years) was higher
than the other group (52.5 years, P < 0.001). In 3848
female participants, the number of post-menopausal
women with diagnostic discordances (951 of 2027) was
significantly higher than pre-menopausal participants
with discordance (671 of 1821; P < 0.001). In multivariate
analysis (Table 4), two genders lost their difference in
occurrence of discordance. Effects of age and menopause
were established with their significant odds ratios. Partic-
ipants with late menopause (age at menopause > 50) were
more likely to show T-score discordances. Obesity defined
as BMI over 30 was recognized as a risk factor for major
discordance and smoking as a protective factor against
minor discordance. Hormone replacement therapy was a
significant protector against both.
Discussion
This study reveals that, using WHO criteria for definition
of osteoporosis and osteopenia, a significant fraction of
patients (41.7% in this study) would show T-score
discordance between hip and spine sites. Most of these
discordances (38.9%) are from minor category, present-
ing difference on only one class, and could be due to
minor variation in BMD techniques or some minor phys-
iologic dissimilarity. Minor discordance generally does
not influence the overall prognosis of patients; however,
in the case of patients with one site normal and the other
osteopenic, follow up of patients with hip osteopenia
seems reasonable [7].
The multivariate analysis we have implemented to the
data could aid clinicians and diagnosticians to approach
patients with different characteristics. According to our
results, BMD measurement in both sites is necessary at
least for older patients and post-menopausal women
especially those with delay in menopause. Hormone
replacement therapy, however, could decrease the diag-
nostic discordance and patients receiving estrogen and
progesterone are more likely to have similar results in
DXA scans of lumbar and femoral areas. This could be the
result of drug effects on the BMD of lumber area [10].
Generally, five different causes have been proposed for
occurrence of discordance [5]. Physiologic discordance is
related to the skeleton's natural adaptive reaction to nor-
mal external and internal factors and forces. An example
of this type of discordance is the difference observed
between the dominant and non-dominant total hip.
Pathophysiologic discordance is seen secondary to a dis-
ease. Common examples include vertebral osteophytosis,
vertebral end plate and facet sclerosis, osteochondrosis,
and aortic calcification. Anatomic discordance is owing to
differences in the composition of bone envelopes tested.
An example is the difference in T-scores found for the PA
lumbar spine and the supine lateral lumbar spine in the
same patient. Artifactual discordance occurs when dense
synthetic substances (such as metal from zipper, coin,
clip, etc) are within the field of region of interest of the
test. And finally, technical discordance occurs when the
technician improperly positions the patient for the test or
the hardware or software used to acquire the test data is
out of order.
Major discordance was observed in 2.7% of our partici-
pants, which is in agreement with the results of similar
studies. In both major and minor discordances, lower
Table 4: Results of multivariate logistic regression analysis for risk factors of major and minor discordance getting T-score 
concordance at lumbar and femoral sites as the reference
Variables Minor Discordance Major Discordance
Gender (female) 1.09 (0.85 – 1.4) 1.02 (0.45 – 2.3)
Age decade 1.2 (1.1 – 1.3)* 1.5 (1.2 – 1.9)*
Age group (>65 years) 1.2 (1.01 – 1.6)* 1.4 (0.70 – 2.7)
Corticosteroid use 0.89 (0.73 – 1.1) 0.71 (0.37 – 1.3)
Body Mass Index (>30 kg/cm2) 1.01 (0.87 – 1.2) 1.7 (1.2 – 2.6)*
History of osteoporotic fracture 1.1 (0.59 – 2.0) 1.3 (0.29 – 5.5)
Smoking 0.66 (0.45 – 0.97)* 0.49 (0.12 – 2.1)
Menopause 1.3 (1.1 – 1.5)* 1.7 (1.01 – 2.7)*
Hormone Replacement Therapy 0.37 (0.16 – 0.82)* 0.54 (0.36 – 0.82)*
Age at menarche (> 13 years) 1.1 (0.90 – 1.3) 0.82 (0.50 – 1.3)
Age at menopause (> 50 years) 1.4 (1.1 – 1.7)* 2.0 (1.2 – 3.4)*
* indicates significant odds ratio. Numbers are presented as odds ratio (95% confidence intervals in parentheses).BMC Endocrine Disorders 2005, 5:3 http://www.biomedcentral.com/1472-6823/5/3
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BMD for lumbar spine was more prevalent. This could be
due to several reasons. The difference between velocities
of bone loss in different parts of human body could be the
main reason [11]. Trabecular bones (typical of lumbar
area) are known to have a more rapid rate of deprivation
in early post-menopausal state in comparison to cortical
bone (typical of proximal femur) [12]. Moreover, most of
the etiologies of the secondary osteoporosis (such as glu-
cocorticoid excess, hyperthyroidism, malabsorption, liver
disease, rheumatoid arthritis, and medications) first affect
spinal column [13]. This will lead to higher prevalence of
lumbar osteoporosis. In addition, weight bearing is a
known cause of physiologic dissimilarity, which can cause
rise in bone density especially in the hip and femur
regions [14]. This mechanism could be the reason of more
major T-score discordances observed by increment of BMI
in this study.
In 30% of our participants, the lumbar T-score was higher
than hip T-score and this culminated in poorer hip diag-
noses in 9.2% of participants. This phenomenon could be
regarded as 'inverse discordance' and several factors may
be involved in its occurrence. One of these reasons is the
prevalent vitamin D deficiency in our participants. A
recent nationwide study with random sampling from five
major cities in Iran reported a high prevalence (about
80%) for vitamin D deficiency in Iranian population [15].
Other studies have confirmed this finding [16,17]. Basic
studies have revealed that decrease in serum concentra-
tions of vitamin D by means of raising serum parathyroid
hormone (PTH) would induce reduction in density of cor-
tical bones and may have a supportive role for density of
trabecular bones [18]. The other reason for 'inverse dis-
cordance' could be due to other diseases such as minor
compression fractures in lumbar area, joint sclerosis, and
aortic calcification [19,20]. These ailments can induce
errors in the estimation of lumbar BMD and falsely higher
values.
The observation of 'inverse discordance' could not be
regarded as a direct influence of more significant bone
loss in femoral region. A known phenomenon named
'birth cohort effect' can play a role [21]. This indicates
that, in the particular section the data have been gathered,
a specific observed finding could not be interpreted for
the effects of age and time passing. In this study, the rea-
son for lower femoral BMD can be insufficient bone gain
during puberty in this area. Latest findings indicates that
peak bone mass of Iranian population are about 5% lower
than that of western population [22,23]. Decreased bone
density in hip region could lead to start of bone loss from
lower amounts in older ages and post-menopausal states.
This can lead to femoral osteoporosis without significant
decrease in lumbar BMD.
This study, as every other cross-sectional study, has a
number of limitations. We could not rule out the possibil-
ity of referral bias for this study. As the study was per-
formed in a referral center affiliated to a teaching hospital,
the assumption of similarity of study population to exact
community is not reasonable and we could not generalize
the results to the Iranian population. The other limitation
is the choice of multivariate analysis used in this study.
With the current analysis, prediction of the presence or
absence of T-score discordances is possible. However, pre-
diction of the situation of one site according to results of
the other site or choosing one site to measure BMD need
further evaluations and analyses which was behind the
scope of this study. Future studies using more powerful
statistical analyses with larger sample sizes are needed to
establish these imperative questions.
The importance of existing discordance on the prognosis
and fracture risk of patients needs further prognostic stud-
ies with long follow-up designs. The high prevalence of T-
score discordance could induce some problems for the
physicians in decision-making regarding these patients. In
general, high prevalence of discordance in this study and
similar studies suggests some defects in the cut-off values
for definition of osteoporosis and osteopenia proposed
with the WHO [5]. To eliminate this problem, further
studies to re-calculate ranges for definition of these diag-
noses (considering diagnostic and therapeutic necessities)
seem to be needed.
Conclusion
In summary, this study indicates that about 40% of partic-
ipants evaluated for bone density changes in a referral
center may show diagnostic discordance, majority of
them from minor class. This phenomenon should be
regarded as a real and prevalent finding and physicians
should become familiar with this topic. Clinicians should
look for possible cause or causes of this occurrence and
develop a particular strategy approaching to these
patients.
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